@phdthesis{Schwab2017,
  author    = {Schwab, Andrea},
  title     = {Development of an osteochondral cartilage defect model},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-155617},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2017},
  abstract  = {The limited intrinsic self-healing capability of articular cartilage requires treatment of cartilage defects. Material assisted and cell based therapies are in clinical practice but tend to result in formation of mechanical inferior fibro-cartilage in long term follow up. If a lesion has not been properly restored degenerative diseases are diagnosed as late sequela causing pain and loss in morbidity. Complex three dimensional tissue models mimicking physiological situation allow investigation of cartilage metabolism and mechanisms involved in repair. A standardized and reproducible model cultured under controllable conditions ex vivo to maintain tissue properties is of relevance for comparable studies. Topic of this thesis was the establishment of an cartilage defect model that allows for testing novel biomaterials and investigate the effect of defined defect depths on formation of repair tissue. In part I an ex vivo osteochondral defect model was established based on isolation of porcine osteochondral explants (OCE) from medial condyles, 8 mm in diameter and 5 mm in height. Full thickness cartilage defects with 1 mm to 4 mm in diameter were created to define ex vivo cartilage critical size after 28 days culture with custom developed static culture device. In part II of this thesis hydrogel materials, namely collagen I isolated from rat tail, commercially available fibrin glue, matrix-metalloproteinase clevable poly(ethylene glycol) polymerized with heparin (starPEGh), methacrylated poly(N-(2-hydroxypropyl) methacrylamide mono-dilactate-poly(ethylene glycol) triblock copolymer/methacrylated hyaluronic acid (MP/HA), thiol functionalized HA/allyl functionalized poly(glycidol) (P(AGE/G)-HA-SH), were tested cell free and chondrocyte loaded (20 mio/ml) as implant in 4 mm cartilage defects to investigate cartilage regeneration. Reproducible chondral defects, 8 mm in diameter and 1 mm in height, were generated with an artificial tissue cutter (ARTcut®) to investigate effect of defect depth on defect regeneration in part III. In all approaches OCE were analyzed by Safranin-O staining to visualize proteoglycans in cartilage and/or hydrogels. Immuno-histological and -fluorescent stainings (aggrecan, collagen II, VI and X, proCollagen I, SOX9, RUNX2), gene expression analysis (aggrecan, collagen II and X, SOX9, RUNX2) of chondrocyte loaded hydrogels (part II) and proteoglycan and DNA content (Part I \& II) were performed for detailed analysis of cartilage regeneration. Part I: The development of custom made static culture device, consisting of inserts in which OCE is fixed and deep well plate, allowed tissue specific media supply without supplementation of TGF � . Critical size diameter was defined to be 4 mm. Part II: Biomaterials revealed differences in cartilage regeneration. Collagen I and fibrin glue showed presence of cells migrated from OCE into cell free hydrogels with indication of fibrous tissue formation by presence of proCollagen I. In chondrocyte loaded study cartilage matrix proteins aggrecan, collagen II and VI and transcription factor SOX9 were detected after ex vivo culture throughout the two natural hydrogels collagen I and fibrin glue whereas markers were localized in pericellular matrix in starPEGh. Weak stainings resulted for MP/HA and P(AGE/G)-HA-SH in some cell clusters. Gene expression data and proteoglycan quantification supported histological findings with tendency of hypertrophy indicated by upregulation of collagen X and RunX2 in MP/HA and P(AGE/G)-HA-SH. Part III: In life-dead stainings recruitment of cells from OCE into empty or cell free collagen I treated chondral defects was seen. Separated and tissue specific media supply is critical to maintain ECM composition in cartilage. Presence of OCE stimulates cartilage matrix synthesis in chondrocyte loaded collagen I hydrogel and reduces hypertrophy compared to free swelling conditions and pellet cultures. Differences in cartilage repair tissue formation resulted in preference of natural derived polymers compared to synthetic based materials. The ex vivo cartilage defect model represents a platform for testing novel hydrogels as cartilage materials, but also to investigate the effect of cell seeding densities, cell gradients, cell co-cultures on defect regeneration dependent on defect depth. The separated media compartments allow for systematic analysis of pharmaceutics, media components or inflammatory cytokines on bone and cartilage metabolism and matrix stability.},
  subject      = {Hyaliner Knorpel},
  language  = {en}
}
@phdthesis{Schweinlin2016,
  author    = {Schweinlin, Matthias Oliver},
  title     = {Development of advanced human intestinal in vitro models},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-142571},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2016},
  abstract  = {The main function of the small intestine is the absorption of essential nutrients, water and vitamins. Moreover, it constitutes a barrier protecting us from toxic xenobiotics and pathogens. For a better understanding of these processes, the development of intestinal in vitro models is of great interest to the study of pharmacological and pathological issues such as transport mechanisms and barrier function. Depending on the scientific questions, models of different complexity can be applied. In vitro Transwell® systems based on a porous PET-membrane enable the standardized study of transport mechanisms across the intestinal barrier as well as the investigation of the influence of target substances on barrier integrity. However, this artificial setup reflects only limited aspects of the physiology of the native small intestine and can pose an additional physical barrier. Hence, the applications of this model for tissue engineering are limited. Previously, tissue models based on a biological decellularized scaffold derived from porcine gut tissue were demonstrated to be a good alternative to the commonly used Transwell® system. This study showed that preserved biological extracellular matrix components like collagen and elastin provide a natural environment for the epithelial cells, promoting cell adhesion and growth. Intestinal epithelial cells such as Caco-2 cultured on such a scaffold showed a confluent, tight monolayer on the apical surface. Additionally, myofibroblasts were able to migrate into the scaffold supporting intestinal barrier formation. In this thesis, dendritic cells were additionally introduced to this model mimicking an important component of the immune system. This co-culture model was then successfully proven to be suitable for the screening of particle formulations developed as delivery system for cancer antigens in peroral vaccination studies. In particular, nanoparticles based on PLGA, PEG-PAGE-PLGA, Mannose-PEG-PAGE-PLGA and Chitosan were tested. Uptake studies revealed only slight differences in the transcellular transport rate among the different particles. Dendritic cells were shown to phagocytose the particles after they have passed the intestinal barrier. The particles demonstrated to be an effective carrier system to transport peptides across the intestinal barrier and therefore present a useful tool for the development of novel drugs. Furthermore, to mimic the complex structure and physiology of the gut including the presence of multiple different cell types, the Caco-2 cell line was replaced by primary intestinal cells to set up a de novo tissue model. To that end, intestinal crypts including undifferentiated stem cells and progenitor cells were isolated from human small intestinal tissue samples (jejunum) and expanded in vitro in organoid cultures. Cells were cultured on the decellularized porcine gut matrix in co-culture with intestinal myofibroblasts. These novel tissue models were maintained under either static or dynamic conditions. Primary intestinal epithelial cells formed a confluent monolayer including the major differentiated cell types positive for mucin (goblet cells), villin (enterocytes), chromogranin A (enteroendocrine cells) and lysozyme (paneth cells). Electron microscopy images depicted essential functional units of an intact epithelium, such as microvilli and tight junctions. FITC-dextran permeability and TEER measurements were used to assess tightness of the cell layer. Models showed characteristic transport activity for several reference substances. Mechanical stimulation of the cells by a dynamic culture system had a great impact on barrier integrity and transporter activity resulting in a tighter barrier and a higher efflux transporter activity. In Summary, the use of primary human intestinal cells combined with a biological decellularized scaffold offers a new and promising way to setup more physiological intestinal in vitro models. Maintenance of primary intestinal stem cells with their proliferation and differentiation potential together with adjusted culture protocols might help further improve the models. In particular, dynamic culture systems and co culture models proofed to be a first crucial steps towards a more physiological model. Such tissue models might be useful to improve the predictive power of in vitro models and in vitro in vivo correlation (IVIVC) studies. Moreover, these tissue models will be useful tools in preclinical studies to test pharmaceutical substances, probiotic active organisms, human pathogenic germs and could even be used to build up patient-specific tissue model for personalized medicine.},
  subject      = {Tissue Engineering},
  language  = {en}
}
@phdthesis{Lodes2021,
  author    = {Lodes, Nina Theresa},
  title     = {Tissue Engineering f{\"u}r seltene Erkrankungen mit St{\"o}rungen des mukozili{\"a}ren Transports},
  doi       = {10.25972/OPUS-20017},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-200178},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2021},
  abstract  = {Bei der zystischen Fibrose (CF) sowie der prim{\"a}ren Ziliendyskinesie (PCD) handelt es sich um zwei seltene Erkrankungen, die unter anderem den mukozili{\"a}ren Transport beeintr{\"a}chtigen. CF geh{\"o}rt hierbei zu den am h{\"a}ufigsten vorkommenden angeborenen Stoffwechselerkrankungen, wobei Betroffene unter einem Defekt des Cystic Fibrosis Transmembrane Conductor Regulator (CFTR)-Gens leiden, der durch die Produktion von hochviskosem Sekret in muzinproduzierenden Organen, wie dem gastrointestinalen Trakt und der Lunge, gekennzeichnet ist. Patienten, die an PCD leiden, weisen Defekte in, zum jetzigen Zeitpunkt, ca. 38 bekannten und PCD-assoziierten Genen auf, die in strukturellen Defekten des zili{\"a}ren Apparats und somit in dysfunktionalen Kinozilien resultieren. Da aktuell weder f{\"u}r die CF noch f{\"u}r die PCD eine Heilung m{\"o}glich ist, steht bei der Therapie vor allem die Linderung der Symptome im Fokus. Grundlegendes Ziel ist der langfristige Erhalt der Lungenfunktion sowie die Pr{\"a}vention bakterieller Infekte. Als bisherige Modellsysteme zur Erforschung m{\"o}glicher Therapeutika gelten Tiermodelle, die den humanen Ph{\"a}notyp aufgrund von Speziesdiversit{\"a}t nicht vollst{\"a}ndig abbilden k{\"o}nnen. Als vielversprechende Testsysteme f{\"u}r die zystische Fibrose gelten humane intestinale Organoidkulturen. Nachdem allerdings vorwiegend respiratorische Symptome f{\"u}r die Mortalit{\"a}t der Patienten verantwortlich sind, stellen CF-Atemwegsmodelle bessere Testsysteme f{\"u}r zuk{\"u}nftige Therapeutika dar. Atmungsorganoidkulturen wurden verwendet, um die CFTR-Funktionalit{\"a}t zu untersuchen, repr{\"a}sentieren aber nicht vollst{\"a}ndig die in vivo Situation. Deshalb werden zur Entwicklung neuer Therapiestrategien patientenspezifische 3D in vitro Testsysteme der humanen Atemwege ben{\"o}tigt, die insbesondere im Hinblick auf personalisierte Medizin ihren Einsatz finden. In der vorliegenden Arbeit wurde eine f{\"u}r den Lehrstuhl neue Methode zur Zellgewinnung aus nasalen Schleimhautabstrichen etabliert, die eine standardisierte Versorgung mit humanem Prim{\"a}rmaterial garantiert. Zur Generierung einer krankheitsspezifischen Zelllinie, wie beispielsweise einer PCD-Zelllinie mit Hilfe des CRISPR/Cas9-Systems, ist eine Atemwegszelllinie erforderlich, die die in vivo Situation vollst{\"a}ndig repr{\"a}sentiert. So wurden vier verschiedene respiratorische Epithelzelllinien (HBEC3-KT, Calu-3, VA10 und Cl-huAEC) auf ihren mukozili{\"a}ren Ph{\"a}notyp hin untersucht, wobei lediglich die Zelllinie HBEC3-KT in zilientragende Zellen differenzierte. Diese zeigten jedoch nur auf ca. 5 \% der Modelloberfl{\"a}che Kinozilien, wodurch die humane respiratorische Mukosa nicht komplett abgebildet werden konnte und die HBEC3-KT-Zelllinie keine geeignete Zelllinie zur Generierung einer PCD-Zelllinie darstellte. Mit Hilfe des Tissue Engineering war es m{\"o}glich, 3D in vitro Testsysteme basierend auf zwei unterschiedlichen Matrices, der biologischen SIS (small intestinal submucosa) und der synthetischen Polyethylenterephthalat (PET)-Membran, aufzubauen. Es wurden 3D Atemwegstestsysteme mit humanen prim{\"a}ren nasalen und tracheobronchialen Epithelzellen generiert. Erg{\"a}nzend zu histologischen Untersuchungen und zur Charakterisierung spezifischer Marker des respiratorischen Systems mittels Immunfluoreszenz, wurde die Ultrastruktur der Modelle, mit speziellem Fokus auf zili{\"a}re Strukturen, analysiert. Um R{\"u}ckschl{\"u}sse auf die zili{\"a}re Funktionalit{\"a}t ziehen zu k{\"o}nnen und somit eine hohe in vivo Korrelation zu best{\"a}tigen, wurde im Rahmen dieser Arbeit am Lehrstuhl f{\"u}r Tissue Engineering und Regenerative Medizin die Methode der Hochgeschwindigkeitsvideomikroskopie etabliert, welche die Analyse der Zilienschlagfrequenz sowie des mukozili{\"a}ren Transports erm{\"o}glicht. Ebenfalls wurde der Einfluss von isotoner Kochsalzl{\"o}sung und des � 2-adrenergen Agonisten Salbutamol, das vor allem als Bronchodilatator bei Asthmapatienten eingesetzt wird, auf die Zilienschlagfrequenz analysiert. Es konnte gezeigt werden, dass beide Substanzen den Zilienschlag im Atemwegsmodell erh{\"o}hen. Zur Generierung der Testsysteme der beiden seltenen Erkrankungen CF und PCD wurden Epithelzellen der betroffenen Patienten zun{\"a}chst mittels nicht-invasiver Raman-Spektroskopie auf einen potentiellen Biomarker untersucht, welcher Einsatz in der Diagnostik der beiden Krankheiten finden k{\"o}nnte. Es konnte jedoch weder f{\"u}r die CF noch f{\"u}r die PCD ein Biomarker aufgedeckt werden. Jedoch zeigten PCD-Zellen eine geringe Auftrennung gegen{\"u}ber nicht-PCD Zellen. Anschließend wurden 3D-Atemwegstestsysteme basierend auf Patientenzellen aufgebaut. Der Ph{\"a}notyp der CF-Modelle wurde mittels immunhistologischer F{\"a}rbung und der Analyse des gest{\"o}rten mukozili{\"a}ren Transports verifiziert. Strukturelle zili{\"a}re Defekte konnten durch die ultrastrukturelle Analyse von Zilienquerschnitten in drei donorspezifischen PCD-Modellen identifiziert werden. Dar{\"u}ber hinaus konnte die zili{\"a}re Funktionalit{\"a}t mit Hilfe der Hochgeschwindigkeitsvideomikroskopie nicht nachgewiesen werden. Zusammenfassend ist es in dieser Arbeit gelungen, eine neue Methode zur vollst{\"a}ndigen Charakterisierung von 3D-Atemwegstestsystemen zu etablieren, die die Analyse der Zilienschlagfrequenz sowie des mukozili{\"a}ren Transports erm{\"o}glicht. Es konnte erstmalig gezeigt werden, dass mit Hilfe des Tissue Engineering ein personalisiertes Krankheitsmodell f{\"u}r die PCD auf Segmenten eines dezellularisierten porzinen Jejunums generiert werden kann, das zuk{\"u}nftig ein Testsystem f{\"u}r potentielle Therapeutika darstellen kann.},
  subject      = {In-vitro-Kultur},
  language  = {de}
}
@phdthesis{RamaniMohan2021,
  author    = {Ramani Mohan, Ramkumar},
  title     = {Effect of Mechanical Stress On Stem Cells to Improve Better Bone Regeneration},
  doi       = {10.25972/OPUS-24013},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-240134},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2021},
  abstract  = {Critical size bone defects and nonunion fractures remain difficult to treat. Although cell-loaded bone substitutes have improved bone ingrowth and formation, the lack of methods for achieving viability and the uniform distribution of cells in the scaffold limits their use as bone grafts. In addition, the predominant mechanical stimulus that drives early osteogenic cell maturation has not been clearly identified. Further, it is challenging to evaluate mechanical stimuli (i.e., deformation and fluid-flow-induced shear stress) because they are interdependent. This thesis compares different mechanical stimuli applied to cell-seeded scaffolds to develop bone grafts efficiently for the treatment of critical size bone defects. It also seeks to understand how deformation strain and interstitial fluid-flow-induced shear stress promote osteogenic lineage commitment. In this thesis, different scaffolds were seeded with primary human bone marrow mesenchymal stem cells (BM-MSCs) from different donors and subjected to static and dynamic culture conditions. In contrast with the static culture conditions, homogenous cell distributions were accomplished under dynamic culture conditions. Additionally, the induction of osteogenic lineage commitment without the addition of soluble factors was observed in the bioreactor system after one week of cell culture. To determine the role of mechanical stimuli, a bioreactor was developed to apply mechanical deformation force to a mesenchymal stem sell (MSC) line (telomerase reverse transcriptase (TERT)) expressing a strain-responsive AP-1 luciferase reporter construct on porous scaffolds. Increased luciferase expression was observed in the deformation strain compared with the shear stress strain. Furthermore, the expression of osteogenic lineage commitment markers such as osteonectin, osteocalcin (OC), osteopontin, runt-related transcription factor 2 (RUNX2), alkaline phosphate (AP), and collagen type 1 was significantly downregulated in the shear stress strain compared with the deformation strain. These findings establish that the deformation strain was the predominant stimulus causing skeletal precursors to undergo osteogenesis in earlier stages of osteogenic cell maturation. Finally, these findings were used to develop a bioreactor in vitro test system in which the effect of medication on osteoporosis could be tested. Primary human BM-MSCs from osteoporotic donors were subjected to strontium ranelate (an osteoporotic drug marketed as Protelos®). Increased expression of collagen type 1 and calcification was seen in the drugtreated osteoporotic stem cells compared with the nondrug-treated osteoporotic stem cells. Thus, this bioreactor technology can easily be adapted into an in vitro osteoporotic drug testing system.},
  language  = {en}
}
@phdthesis{Fey2022,
  author    = {Fey, Christina},
  title     = {Establishment of an intestinal tissue model for pre-clinical screenings},
  doi       = {10.25972/OPUS-24410},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-244107},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2022},
  abstract  = {The small intestine represents a strong barrier separating the lumen from blood circulation thereby playing a major role in the absorption and the transport of pharmacological agents prior to their arrival on the respective target site. In order to gain more knowledge about specialized uptake mechanisms and risk assessment for the patient after oral admission of drugs, intestinal in vitro models demonstrating a close similarity to the in vivo situation are needed. In the past, cell line-based in vitro models composed of Caco-2 cells cultured on synthetic cell carriers represented the "gold standard" in the field of intestinal tissue engineering. Expressive advantages of these models are a reproducible, cost-efficient and standardized model set up, but cell function can be negatively influenced by the low porosity or unwanted molecular adhesion effects of the artificial scaffold material. Natural extracellular matrices (ECM) such as the porcine decellularized small intestinal submucosa (SIS) are used as alternative to overcome some common drawbacks; however, the fabrication of these scaffolds is time- and cost-intensive, less well standardized and the 3Rs (replacement, reduction, refinement) principle is not entirely fulfilled. Nowadays, biopolymer-based scaffolds such as the bacterial nanocellulose (BNC) suggest an interesting option of novel intestinal tissue engineered models, as the BNC shows comparable features to the native ECM regarding fiber arrangement and hydrophilic properties. Furthermore, the BNC is of non-animal origin and the manufacturing process is faster as well as well standardized at low costs. In this context, the first part of this thesis analyzed the BNC as alternative scaffold to derive standardized and functional organ models in vitro. Therefore, Caco-2 cells were cultured on two versions of BNC with respect to their surface topography, the unmodified BNC as rather smooth surface and the surface-structured BNC presenting an aligned fiber arrangement. As controls, Caco-2 in vitro models were set up on PET and SIS matrices. In this study, the BNC-based models demonstrated organ-specific properties comprising typical cellular morphologies, a characteristic tight junction protein expression profile, representative ultrastructural features and the formation of a tight epithelial barrier together with a corresponding transport activity. In summary, these results validated the high quality of the BNC-based Caco-2 models under cost-efficient conditions and their suitability for pre-clinical research purposes. However, the full functional diversity of the human intestine cannot be presented by Caco-2 cells due to their tumorigenic background and their exclusive representation of mature enterocytes. Next to the scaffold used for the setup of in vitro models, the cellular unit mainly drives functional performance, which demonstrates the crucial importance of mimicking the cellular diversity of the small intestine in vitro. In this context, intestinal primary organoids are of high interest, as they show a close similarity to the native epithelium regarding their cellular diversity comprising enterocytes, goblet cells, enteroendocrine cells, paneth cells, transit amplifying cells and stem cells. In general, such primary organoids grow in a 3D Matrigel® based environment and a medium formulation supplemented with a variety of growth factors to maintain stemness, to inhibit differentiation and to stimulate cell migration supporting long term in vitro culture. Intestinal primary spheroid/organoid cultures were set up as Transwell®-like models on both BNC variants, which resulted in a fragmentary cell layer and thereby unfavorable properties of these scaffold materials under the applied circumstances. As the BNC manufacturing process is highly flexible, surface properties could be adapted in future studies to enable a good cell adherence and barrier formation for primary intestinal cells, too. However, the application of these organoid cultures in pre-clinical research represents an enormous challenge, as the in vitro culture is complex and additionally time- and cost-intensive. With regard to the high potential of primary intestinal spheroids/organoids and the necessity of a simplified but predictive model in pre-clinical research purposes, the second part of this thesis addressed the establishment of a primary-derived immortalized intestinal cell line, which enables a standardized and cost-efficient culture (including in 2D), while maintaining the cellular diversity of the organoid in vitro cultures. In this study, immortalization of murine and human intestinal primary organoids was induced by ectopic expression of a 10- (murine) or 12 component (human) pool of genes regulating stemness and the cell cycle, which was performed in cooperation with the InSCREENeX GmbH in a 2D- and 3D-based transduction strategy. In first line, the established cell lines (cell clones) were investigated for their cell culture prerequisites to grow under simplified and cost-efficient conditions. While murine cell clones grew on uncoated plastic in a medium formulation supplemented with EGF, Noggin, Y-27632 and 10\% FCS, the human cell clones demonstrated the necessity of a Col I pre coating together with the need for a medium composition commonly used for primary human spheroid/organoid cultures. Furthermore, the preceding analyses resulted in only one human cell clone and three murine cell clones for ongoing characterization. Studies regarding the proliferative properties and the specific gene as well as protein expression profile of the remaining cell clones have shown, that it is likely that transient amplifying cells (TACs) were immortalized instead of the differentiated cell types localized in primary organoids, as 2D, 3D or Transwell®-based cultures resulted in slightly different gene expression profiles and in a dramatically reduced mRNA transcript level for the analyzed marker genes representative for the differentiated cell types of the native epithelium. Further, 3D cultures demonstrated the formation of spheroid-like structures; however without forming organoid-like structures due to prolonged culture, indicating that these cell populations have lost their ability to differentiate into specific intestinal cell types. The Transwell®-based models set up of each clone exhibit organ-specific properties comprising an epithelial-like morphology, a characteristic protein expression profile with an apical mucus-layer covering the villin-1 positive cell layer, thereby representing goblet cells and enterocytes, together with representative tight junction complexes indicating an integer epithelial barrier. The proof of a functional as well as tight epithelial barrier in TEER measurements and in vivo-like transport activities qualified the established cell clones as alternative cell sources for tissue engineered models representing the small intestine to some extent. Additionally, the easy handling and cell expansion under more cost-efficient conditions compared to primary organoid cultures favors the use of these newly generated cell clones in bioavailability studies. Altogether, this work demonstrated new components, structural and cellular, for the establishment of alternative in vitro models of the small intestinal epithelium, which could be used in pre-clinical screenings for reproducible drug delivery studies.},
  subject      = {D{\"u}nndarm},
  language  = {en}
}
@phdthesis{Leikeim2022,
  author    = {Leikeim, Anna},
  title     = {Vascularization Strategies for Full-Thickness Skin Equivalents to Model Melanoma Progression},
  doi       = {10.25972/OPUS-27295},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-272956},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2022},
  abstract  = {Malignant melanoma (MM) is the most dangerous type of skin cancer with rising incidences worldwide. Melanoma skin models can help to elucidate its causes and formation or to develop new treatment strategies. However, most of the current skin models lack a vasculature, limiting their functionality and applicability. MM relies on the vascular system for its own supply and for its dissemination to distant body sites via lymphatic and blood vessels. Thus, to accurately study MM progression, a functional vasculature is indispensable. To date, there are no vascularized skin models to study melanoma metastasis in vitro, which is why such studies still rely on animal experimentation. In the present thesis, two different approaches for the vascularization of skin models are employed with the aim to establish a vascularized 3D in vitro full-thickness skin equivalent (FTSE) that can serve as a test system for the investigation of the progression of MM. Initially, endothelial cells were incorporated in the dermal part of FTSEs. The optimal seeding density, a spheroid conformation of the cells and the cell culture medium were tested. A high cell density resulted in the formation of lumen-forming shapes distributed in the dermal part of the model. These capillary-like structures were proven to be of endothelial origin by staining for the endothelial cell marker CD31. The established vascularized FTSE (vFTSE) was characterized histologically after 4 weeks of culture, revealing an architecture similar to human skin in vivo with a stratified epidermis, separated from the dermal equivalent by a basement membrane indicated by collagen type IV. However, this random capillary-like network is not functional as it cannot be perfused. Therefore, the second vascularization approach focused on the generation of a perfusable tissue construct. A channel was molded within a collagen hydrogel and seeded with endothelial cells to mimic a central, perfusable vessel. The generation and the perfusion culture of the collagen hydrogel was enabled by the use of two custom-made, 3D printed bioreactors. Histological assessment of the hydrogels revealed the lining of the channel with a monolayer of endothelial cells, expressing the cell specific marker CD31. For the investigation of MM progression in vitro, a 3D melanoma skin equivalent was established. Melanoma cells were incorporated in the epidermal part of FTSEs, representing the native microenvironment of the tumor. Melanoma nests grew at the dermo-epidermal junction within the well stratified epidermis and were characterized by the expression of common melanoma markers. First experiments were conducted showing the feasibility of combining the melanoma model with the vFTSE, resulting in skin models with tumors at the dermo-epidermal junction and lumen-like structures in the dermis. Taken together, the models presented in this thesis provide further steps towards the establishment of a vascularized, perfusable melanoma model to study melanoma progression and metastasis.},
  subject      = {Tissue Engineering},
  language  = {en}
}
@phdthesis{Lotz2019,
  author    = {Lotz, Christian},
  title     = {Entwicklung eines Augenirritationstests zur Identifikation aller GHS-Kategorien f{\"u}r den Endpunkt Augenreizung},
  doi       = {10.25972/OPUS-17012},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-170126},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Die Risikobewertung von Chemikalien ist f{\"u}r die {\"o}ffentliche Gesundheit von entschei-dender Bedeutung, weshalb strenge Testverfahren zu deren toxikologischer Begutach-tung angewandt werden. Die urspr{\"u}nglich tierbasierten Testverfahren werden aufgrund von neuen wissenschaftlichen Erkenntnissen und wegen {\"o}konomischer Ineffizienz sowie ethischer Fragw{\"u}rdigkeit immer mehr durch alternative Methoden ohne Tiermodelle ersetzt. F{\"u}r den toxikologischen Endpunkt der Augenreizung wurden bereits die ersten alternativen Testsysteme auf der Basis von ex vivo- oder in vitro-Modellen entwickelt. Jedoch ist bis dato kein alternatives Testsystem in der Lage, das gesamte Spektrum der verschiedenen Kategorien der Augenreizungen nach dem global harmonisierten System zur Einstufung und Kennzeichnung von Chemikalien (GHS) vorherzusagen und damit den tierbasierten Draize-Augenreizungstest vollends zu ersetzen. Gr{\"u}nde hierf{\"u}r sind fehlende physiologische Merkmale im Modell sowie eine destruktive Analysemethode. Aufgrund dessen wurden in dieser Studie die Hypothesen getestet, ob ein verbessertes In-vitro-Modell oder eine zerst{\"o}rungsfreie, hochsensitive Analysemethode die Vorher-sagekraft des Augenreizungstests verbessern k{\"o}nnen. Daf{\"u}r wurden zun{\"a}chst neue Mo-delle aus humanen Hornhaut- und Hautepithelzellen entwickelt. Die Modelle aus pri-m{\"a}ren cornealen Zellen zeigten eine gewebespezifische Expression der Marker Zytokera-tin 3 und 12 sowie Loricrin. In beiden Modellen konnte durch die Verk{\"u}rzung der Kul-turdauer die Ausbildung einer Hornschicht verhindert werden. Die Modelle wiesen dadurch eine sensiblere Barriere vergleichbar der nativen Cornea auf. Dar{\"u}ber hinaus konnte durch die chemische Quervernetzung mit Polyethylenglykolsuccinimidylglutara-tester ein transparentes, nicht kontrahierendes Stroma-{\"A}quivalent etabliert werden. Der Stroma-Ersatz konnte zur Generierung von Hemi- und Voll-Cornea-{\"A}quivalenten einge-setzt werden und lieferte somit erste Ansatzpunkte f{\"u}r die Rekonstruktion der nativen Hornhaut. Parallel dazu konnte ein zerst{\"o}rungsfreies Analyseverfahren basierend auf der Impe-danzspektroskopie entwickelt werden, das wiederholte Messungen der Gewebeintegri-t{\"a}t zul{\"a}sst. Zur verbesserten Messung der Barriere in dreidimensionalen Modelle wurde hierf{\"u}r ein neuer Parameter, der transepitheliale elektrische Widerstand (TEER) bei der Frequenz von 1000 Hz, der TEER1000 Hz definiert, der eine genauere Aussage {\"u}ber die Integrit{\"a}t der Modelle zul{\"a}sst. Durch die Kombination der entwickelten cornealen Epithelzellmodelle mit der TEER1000 Hz-Messung konnte die Pr{\"a}dikitivit{\"a}t des Augenrei-zungstests auf 78 - 100 \% erh{\"o}ht werden. Von besonderer Bedeutung ist dabei, dass die nicht destruktive Messung des TEER1000 Hz zum ersten Mal erlaubte, die Persistenz von Irritationen durch wiederholte Messungen in einem in vitro-Modell zu erkennen und somit die GHS-Kategorie 1 von GHS-Kategorie 2 zu unterscheiden. Der wissenschaftli-che Gewinn dieser Forschungsarbeit ist ein neues Testverfahren, das alle GHS-Kategorien in einem einzigen in vitro-Test nachweisen und den Draize-Augenreizungstest g{\"a}nzlich ersetzen kann.},
  subject      = {Tissue Engineering},
  language  = {de}
}
@phdthesis{Siverino2020,
  author    = {Siverino, Claudia},
  title     = {Induction of ectopic bone formation by site directed immobilized BMP2 variants \(in\) \(vivo\)},
  doi       = {10.25972/OPUS-16935},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-169359},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2020},
  abstract  = {In contrast to common bone fractures, critical size bone defects are unable to self-regenerate and therefore external sources for bone replacement are needed. Currently, the gold standard to treat critical size bone fractures, resulting from diseases, trauma or surgical interventions, is the use of autologous bone transplantation that is associated with several drawbacks such as postoperative pain, increased loss of blood during surgery and extended operative time. The field of bone tissue engineering focuses on the combination of biomaterials and growth factors to circumvent these adverse events and thereby to improve critical size bone defects treatment. To this aim, a promising approach is represented by using a collagen sponge soaked with one of the most powerful osteoinductive proteins, the bone morphogenetic protein 2 (BMP2). After the approval by the Food and Drug Administration (FDA), BMP2 was used to successfully treat several severe bone defects. However, the use of BMP2 delivery systems is associated with severe side effects such as inflammation, swelling, ectopic bone formation outside of the site of implantation and breathing problems if implanted in the area of the cervical spine. The occurrence of severe side effects is related to the supraphysiological amounts of the applied protein at the implantation site. The BMP2 is typically adsorbed into the scaffold and diffuses rapidly after implantation. Therefore, intensive research has been conducted to improve the protein's retention ability, since a prolonged entrapment of the BMP2 at the implantation site would induce superior bone formation in vivo due to a minimized protein release. By controlling the release from newly designed materials or changing the protein immobilization methods, it seems possible to improve the osteoinductive properties of the resulting BMP2-functionalized scaffolds. The combination of biocompatible and biodegradable scaffolds functionalized with a covalently immobilized protein such as BMP2 would constitute a new alternative in bone tissue engineering by eliminating the aforementioned severe side effects. One of the most common immobilization techniques is represented by the so-called EDC/NHS chemistry. This coupling technique allows covalent biding of the growth factor but in a non-site direct manner, thus producing an implant with uncontrollable and unpredictable osteogenic activities. Therefore, the generation of BMP2 variants harboring functional groups that allow a site-directed immobilization to the scaffold, would enable the production of implants with reproducible osteogenic activity. The new BMP2 variants harbor an artificial amino acid at a specific position of the mature polypeptide sequence. The presence of the unnatural amino acid allows to use particular covalent immobilization techniques in a highly specific and site directed manner. The two selected BMP2 variants, BMP2 E83Plk and BMP2 E83Azide, were expressed in E. coli, renatured and purified by cation exchange chromatography. The final products were intensively analyzed in terms of purity and biological activity in vitro. The two BMP2 variants enabled the application of different coupling techniques and verify the possible options for site directed immobilization to the scaffold. Intensive analyses on the possible side effects caused by the coupling reactions and on the quantification of the coupled protein were performed. Both click chemistry reactions showed high reaction efficacies when the BMP2 variants were coupled to functionalized fluorophores. Quantification by ELISA and scintillation counting of radioactively labeled protein revealed different outcomes. Moreover, the amounts of protein detected for the BMP2 variants coupled to microspheres were similar to that of the wild type protein. Therefore, it was not possible to conclude whether the BMP2 variants were covalently coupled or just adsorbed. BMP2 variants being immobilized to various microspheres induced osteogenic differentiation of C2C12 cells in vitro, but only in those cells that were located in close proximity to the functionalized beads. This selectivity strongly indicates that the protein is for a great portion covalently coupled and not just adsorbed. Moreover, the difference between the covalently coupled BMP2 variants and the adsorbed BMP2 WT was confirmed in vivo. Injection of the BMP2-functionalized microspheres in a rat model induced subcutaneous bone formation. The main aim of the animal experiment was to prove whether covalently coupled BMP2 induces bone formation at significant lower doses if compared to the amount being required if the protein is simply adsorbed. To this aim, several BMP2 concentrations were tested in this animal experiment. The BMP2 variants, being covalently immobilized, were hypothesized to be retained and therefore bio-available at the site of implantation for a prolonged time. However, in the animal experiments, lower doses of either coupled or adsorbed protein were unable to induce any bone formation within the 12 weeks. In contrast, the highest doses induced bone formation that was first detected at week 4. During the 12 weeks of the experiment, an increase in bone density and a steady state bone volume was observed. These results were obtained only for the covalently coupled BMP2 E83Azide but not for BMP2 E83Plk that did not induce bone formation in any condition. The negative outcome after application of BMP2 E83Plk suggested that the coupling reaction might have provoked changes in the protein structure that extremely influenced its osteogenic capabilities in vivo. However, the histological examination of the different ossicles induced either by BMP2 WT or BMP2 E83Azide, revealed clear morphological differences. BMP2 WT induced a bone shell-like structure, while the covalently coupled protein induced uniform bone formation also throughout the inner part. The differences between the two newly formed bones can be clearly associated with the different protein delivery mechanisms. Thus, the developed functionalized microspheres constitute a new interesting strategy that needs further investigations in order to be able to be used as replacement of the currently used BMP2 WT loaded medical devices.},
  language  = {en}
}
@phdthesis{Tabisz2017,
  author    = {Tabisz, Barbara},
  title     = {Site Directed Immobilization of BMP-2: Two Approaches for the Production of Osteoinductive Scaffolds},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-153766},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2017},
  abstract  = {Bone fractures typically heal without surgical intervention. However, pathological situations exist which impede the healing process resulting in so-called non-union fractures. Such fractures are nowadays treated with scaffold material being introduced into the defect area. These scaffolds can be doped with osteogenic factors, such as bone morphogenetic protein (BMP)2. BMP2 belongs to the most osteogenic growth factors known to date. Its medical use, efficiency and safety have been approved by FDA for certain applications. Currently, BMP2 is distributed with a stabilizing scaffold, which is simply soaked with the growth factor. Due to fast release kinetics supraphysiological high doses of BMP2 are required which are causally associated with severe side effects observed in certain applications being most harmful in the area of the cervical spine. These side-effects include inflammation, swelling and breathing problems, leading to disastrous consequences or secondary surgical interventions. Since it could be shown that a retardation of BMP2 release from the scaffold resulted in superior bone forming properties in vivo, it seems obvious to further reduce this release to a minimum. This can be achieved by covalent coupling which in the past was already elaborated using mainly classical EDC/NHS chemistry. Using this technique coupling of the protein occurs non-site-directedly leading mainly to an unpredictable product outcome with variable osteogenic activities. In order to improve the reproducibility of scaffold functionalization by BMP2 we created variants one of which contains a unique unnatural amino acid substitution within the mature polypeptide sequence (BMP2-K3Plk) and another, BMP2-A2C, in which an N-terminal alanine has been substituted by cysteine. These modifications enable site-specific and covalent immobilization of BMP2 e.g. onto polymeric beads. Both proteins were expressed in E. coli, renatured and purified by cation-exchange chromatography. Both variants were extensively analyzed in terms of purity and biological activity which was tested by in vitro interaction analyses as well as in cell based assays. Both proteins could be successfully coupled to polymeric beads. The different BMP2 functionalized beads were shown to interact with the ectodomain of the type I receptor BMPR-IA in vitro indicating that the biological activity of both BMP2 variants retained upon coupling. Both functionalized beads induced osteogenic differentiation C2C12 cells but only of those cells which have been in close contact to the particular beads. This strongly indicates that the BMP2 variant are indeed covalently coupled and not just adsorbed. We claim that we have developed a system for a site-specific and covalent immobilization of BMP-2 onto solid scaffolds, potentially eliminating the necessity of high-dose scaffold loading. Since immobilized proteins are protected from removal by extracellular fluids, their activities now rely mainly on the half-life of the used scaffold and the rate of proteolytic degradation. Assuming that due to prolonged times much lower loading capacities might be required we propose that the immobilization strategy employed in this work may be further refined and optimized to replace the currently used BMP2-containing medical products.},
  subject      = {Protein chemistry},
  language  = {en}
}
@phdthesis{Jannasch2019,
  author    = {Jannasch, Maren Annika},
  title     = {In vitro Fremdk{\"o}rpermodellsysteme zur Vorhersage von biomaterialinduzierten Immunreaktionen},
  doi       = {10.25972/OPUS-16289},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-162893},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Die Implantation eines Medizinprodukts in den menschlichen K{\"o}rper ruft eine Immunreaktion hervor, die zur fibr{\"o}sen Einkapselung f{\"u}hren kann. Makrophagen in direktem Kontakt mit der Oberfl{\"a}che des Implantats erfassen sensorisch den Fremdk{\"o}rper und {\"u}bersetzten das Signal in die Freisetzung zahlreicher l{\"o}slicher Mediatoren. Das generierte Entz{\"u}ndungsmilieu moduliert die Heilungsreaktion und kann zur Anreicherung von Fibroblasten sowie zur Erh{\"o}hung der Matrixsyntheserate in der Wundumgebung f{\"u}hren. Eine dichte fibr{\"o}se Kapsel um ein Medizinprodukt beeintr{\"a}chtigt den Ersatz von K{\"o}rperstrukturen, das Unterst{\"u}tzen physiologischer K{\"o}rperfunktionen sowie die Effizienz einer medizinischen Therapie. Zur Identifizierung potenzieller Biomaterialkandidaten mit optimalen Eigenschaften ist jedoch eine evidenzbasierte Entscheidungsfindung notwendig und diese wiederum muss durch geeignete Testmethoden unterst{\"u}tzt werden. Zur Erfassung lokaler Effekte nach Implantation eines Biomaterials begr{\"u}ndet die Komplexi-t{\"a}t der ablaufenden Fremdk{\"o}rperreaktion die Anwendung von Tiermodellen als Goldstandard. Die Eingliederung von in vitro Modellsystemen in standardisierte Testverfahren scheitert oft an der Verf{\"u}gbarkeit validierter, verl{\"a}sslicher und reproduzierbarer Methoden. Demnach ist kein standardisiertes in vitro Testverfahren beschrieben, das die komplexen dreidimensionalen Gewebsstrukturen w{\"a}hrend einer Fremdk{\"o}rperreaktion abbildet und sich zur Testung {\"u}ber l{\"a}ngere Kontaktphasen zwischen Blutkomponenten und Biomaterialien eignet. Jedoch k{\"o}nnen in vitro Testungen kosten- und zeiteffizienter sein und durch die Anwendung humaner Zellen eine h{\"o}here {\"U}bertragbarkeit auf den Menschen aufweisen. Zus{\"a}tzlich adressiert die Pr{\"a}ferenz zu in vitro Testmethoden den Aspekt „Reduzierung" der 3R-Prinzipien „Replacement, Reduction, Refinement" (Ersatz, Reduzierung, Verbesserung) von Russel und Burch (1959) zu einer bewussten und begr{\"u}ndeten Anwendung von Tiermodellen in der Wissenschaft. Ziel von diesem Forschungsvorhaben war die Entwicklung von humanen in vitro Modellsystemen, die den Kontakt zu Blutkomponenten sowie die Reaktion des umliegenden Bindegewebes bei lokaler Implantation eines Biomaterials abbilden. Referenzmaterialien, deren Gewebsantwort nach Implantation in Tiere oder den Menschen bekannt ist, dienten als Validierungskriterium f{\"u}r die entwickelten Modellsysteme. Die Anreicherung von Zellen sowie die Bildung extrazellul{\"a}rer Matrix in der Wundumgebung stellen wichtige Teilprozesse w{\"a}hrend einer Fremdk{\"o}rperreaktion dar. F{\"u}r beide Teilprozesse konnte in einem indirekten zellbasierten Modellsystem der Einfluss einer zellvermittelten Konditionierung wie die Freisetzung von l{\"o}slichen Mediatoren durch materialadh{\"a}rente Makrophagen auf die gerichtete Wanderung von Fibroblasten sowie den Umbau eines dreidimensionalen Bindegewebsmodells aufgezeigt werden. Des Weiteren ließ sich das Freisetzungsprofil von Zytokinen durch materialst{\"a}ndige Makrophagen unter verschiedenen Testbedingungen wie der Kontamination mit LPS, der Oberfl{\"a}chenbehandlung mit humanem Blutplasma und der Gegenwart von IL-4 bestimmen. Die anschließende vergleichende statistische Modellierung der generierten komplexen multifaktoriellen Datenmatrix erm{\"o}glichte die {\"U}bersetzung in eine Biomaterialbewertung. Dieses entwickelte Testverfahren eignete sich einerseits zur Validierung von in vitro Testbedingungen sowie andererseits zur Bewertung von Biomaterialien. Dar{\"u}ber hinaus konnte in einem dreidimensionalen Fremdk{\"o}rpermodell die komplexe dreidimensionale Struktur der extrazellul{\"a}ren Matrix in einer Wunde durch die Kombination unterschiedlicher Zell- und Matrixkomponenten biomimetisch nachgebaut werden. Diese neuartigen dreidimensionalen Fremdk{\"o}rpermodelle erm{\"o}glichten die Testung von Biomaterialien {\"u}ber l{\"a}ngere Testphasen und k{\"o}nnen in anschließenden Studien angewandt werden, um dynamische Prozesse zu untersuchen. Zusammenfassend konnten in dieser Arbeit drei unterschiedliche Teststrategien entwickelt werden, die (I) die Bewertung von Teilprozessen erm{\"o}glichen, (II) die Identifizierung verl{\"a}sslicher Testbedingungen unterst{\"u}tzen und (III) biomimetisch ein Wundgewebe abbilden. Wesentlich ist, dass biomimetisch ein dreidimensionales Gewebemodell entwickelt werden konnte, das eine verl{\"a}ssliche Unterscheidungskapazit{\"a}t zwischen Biomaterialien aufweist.},
  subject      = {Biomaterial},
  language  = {de}
}